# Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma

> **NCT02024373** · PHASE2 · COMPLETED · sponsor: **Oriental Neurosurgery Evidence-Based-Study Team** · enrollment: 200 (actual)

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02024373
- **Lead sponsor:** Oriental Neurosurgery Evidence-Based-Study Team
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-04
- **Final completion:** 2016-09
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024373, "Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02024373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*